In addition, to further determine whether METTL3 is an important functional downstream target of YY1 in AML cells, we performed METTL3 overexpression after YY1 was knocked down and assessed cell proliferation using EdU, CCK-8, and colony formation assays. The gene discussed is YY1; the disease is acute myeloid leukemia.